Corcept Therapeutics (CORT) Enterprise Value: 7.700B

Corcept Therapeutics, Inc. (CORT)

72.96 -0.75 (-1.02%) USD | NASDAQ | Nov 13, 16:00

72.96 0.00 (0.00%) After-Hours: 16:53

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2004. Start Trial.

Date	Value
November 12, 2026	7.700B
November 11, 2026	7.789B
November 10, 2026	7.660B
November 09, 2026	7.843B
November 06, 2026	7.597B
November 05, 2026	7.472B
November 04, 2026	8.302B
November 03, 2026	8.599B
November 02, 2026	8.438B
October 30, 2026	8.510B
October 29, 2026	9.038B
October 28, 2026	9.074B
October 27, 2026	9.218B
October 26, 2026	9.167B
October 23, 2026	9.028B
October 22, 2026	11.40B
October 21, 2026	12.36B
October 20, 2026	12.37B
October 19, 2026	11.90B
October 16, 2026	11.69B
October 15, 2026	12.04B
October 14, 2026	12.35B
October 13, 2026	12.52B
October 12, 2026	12.89B
October 09, 2026	12.89B

Date	Value
October 08, 2026	12.60B
October 07, 2026	12.72B
October 06, 2026	12.72B
October 05, 2026	12.98B
October 02, 2026	12.35B
October 01, 2026	12.11B
September 30, 2026	12.24B
September 29, 2026	12.08B
September 28, 2026	12.18B
September 25, 2026	12.23B
September 24, 2026	12.49B
September 23, 2026	11.89B
September 22, 2026	12.38B
September 21, 2026	11.98B
September 18, 2026	11.60B
September 17, 2026	12.10B
September 16, 2026	11.77B
September 15, 2026	11.66B
September 14, 2026	11.77B
September 11, 2026	11.87B
September 10, 2026	12.10B
September 09, 2026	12.19B
September 08, 2026	12.00B
September 04, 2026	11.75B
September 03, 2026	11.87B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks